HOSPITAL DE PEDIATRIA SAMIC PROF. DR. JUAN P. GARRAHAN

Their core work

Hospital Garrahan is Argentina's largest public pediatric hospital and one of Latin America's leading centers for complex childhood disease. They provide clinical research infrastructure — patient cohorts, diagnostic capacity, and specialist medical teams — for international research consortia working on rare and severe pediatric conditions. In H2020, they have contributed to Zika virus surveillance in pregnant women and newborns, and to multi-center studies on childhood leukemia subtypes. Their core value to European partners is access to large South American patient populations and clinical expertise in conditions that require global cohorts to study effectively.

What they specialise in

How they've shifted over time

In their first H2020 project (2016), Garrahan's contribution was squarely in infectious disease preparedness — Zika virus, vertical transmission, congenital infection, immunology, and neonatal diagnostics during an active public health emergency. By 2019, their focus had shifted toward childhood cancer: leukemia subtypes, translational research, and long-term clinical follow-up within a structured South America–Europe collaboration. The trajectory suggests a deliberate move from emergency-response network science toward sustained oncology research programs, likely reflecting the hospital's growing hematology-oncology department capacity.

Garrahan appears to be deepening its role as a Latin American clinical anchor for European pediatric oncology research — partners building leukemia, rare disease, or global pediatric cohort studies should consider them a strategic southern-hemisphere node.

How they like to work

Garrahan has participated exclusively as a consortium partner, never as coordinator — consistent with a clinical hospital whose strength lies in patient access and data contribution rather than project management. With 29 unique partners across just 2 projects, they operate within large, geographically distributed consortia, suggesting they are comfortable integrating into complex multi-site research networks. They are a specialist contributor: recruited for what they uniquely provide (South American pediatric cohorts) rather than for administrative or technical leadership.

Garrahan has worked with 29 distinct partners across 12 countries through just two projects — an unusually broad network for a two-project participant, indicating they join large international consortia. Their partnerships span both European research institutions and Latin American clinical centers, positioning them as a trans-Atlantic bridge organization.

What sets them apart

Garrahan is one of very few Latin American institutions participating in H2020 health research, which makes it a rare and high-value entry point for European consortia that need non-EU clinical data or wish to demonstrate global impact. As Argentina's flagship pediatric hospital — handling the most complex cases in the country — it offers patient volumes and disease diversity that smaller or wealthier health systems cannot replicate. For any pediatric study requiring South American cohorts, Garrahan is effectively irreplaceable as a partner.

Highlights from their portfolio

• CLOSER
  The largest of Garrahan's funded projects (EUR 545,815), CLOSER is explicitly designed to bridge South American and European research on childhood leukemia subtypes — making Garrahan's role structurally central to the consortium's geographic rationale.
• ZIKAction
  Garrahan joined ZIKAction at the height of the 2016 Zika emergency, demonstrating the hospital's capacity to mobilize rapidly for international outbreak-response research networks involving pregnant women and neonates.